ArticleEJHaem2026

Effectiveness and Safety of Prophylactic Low-Dose Emicizumab in Young Children With Hemophilia A: A Multicenter Retrospective Study.

Guichi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.